Nivolumab and ipilimumab combination therapy for melanoma efficacy, safety and clinical integration in metastatic and adjuvant settings. - Afuh R; Ashinze P; Banerjee S; Egbunu E; Olaniyan MO; Ayo-Ige AB; Soyinka EK; Atere AO; Igwe S; Oladipupo YM; Obaoye A; Nasiru Y; et al. (Discover oncology, 2026)